These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1226 related items for PubMed ID: 21451212

  • 1. Nitric oxide (NO)-releasing aspirin exhibits a potent esophagoprotection in experimental model of acute reflux esophagitis. Role of nitric oxide and proinflammatory cytokines.
    Pawlik M, Pajdo R, Kwiecien S, Ptak-Belowska A, Sliwowski Z, Mazurkiewicz-Janik M, Konturek SJ, Pawlik WW, Brzozowski T.
    J Physiol Pharmacol; 2011 Feb; 62(1):75-86. PubMed ID: 21451212
    [Abstract] [Full Text] [Related]

  • 2. Esophagoprotective activity of angiotensin-(1-7) in experimental model of acute reflux esophagitis. Evidence for the role of nitric oxide, sensory nerves, hypoxia-inducible factor-1alpha and proinflammatory cytokines.
    Pawlik MW, Kwiecien S, Pajdo R, Ptak-Belowska A, Brzozowski B, Krzysiek-Maczka G, Strzalka M, Konturek SJ, Brzozowski T.
    J Physiol Pharmacol; 2014 Dec; 65(6):809-22. PubMed ID: 25554985
    [Abstract] [Full Text] [Related]

  • 3. Healing of chronic gastric ulcers in diabetic rats treated with native aspirin, nitric oxide (NO)-derivative of aspirin and cyclooxygenase (COX)-2 inhibitor.
    Brzozowska I, Targosz A, Sliwowski Z, Kwiecien S, Drozdowicz D, Pajdo R, Konturek PC, Brzozowski T, Pawlik M, Konturek SJ, Pawlik WW, Hahn EG.
    J Physiol Pharmacol; 2004 Dec; 55(4):773-90. PubMed ID: 15613743
    [Abstract] [Full Text] [Related]

  • 4. Antibiotic treatment with ampicillin accelerates the healing of colonic damage impaired by aspirin and coxib in the experimental colitis. Importance of intestinal bacteria, colonic microcirculation and proinflammatory cytokines.
    Zwolinska-Wcislo M, Krzysiek-Maczka G, Ptak-Belowska A, Karczewska E, Pajdo R, Sliwowski Z, Urbanczyk K, Drozdowicz D, Konturek SJ, Pawlik WW, Brzozowski T.
    J Physiol Pharmacol; 2011 Jun; 62(3):357-68. PubMed ID: 21893697
    [Abstract] [Full Text] [Related]

  • 5. Esophagoprotection mediated by exogenous and endogenous melatonin in an experimental model of reflux esophagitis.
    Konturek PC, Brzozowska I, Targosz A, Pawlik M, Kania J, Hess T, Kwiecien S, Konturek SJ, Reiter RJ, Brzozowski T.
    J Pineal Res; 2013 Aug; 55(1):46-57. PubMed ID: 23480366
    [Abstract] [Full Text] [Related]

  • 6. Classic NSAID and selective cyclooxygenase (COX)-1 and COX-2 inhibitors in healing of chronic gastric ulcers.
    Brzozowski T, Konturek PC, Konturek SJ, Sliwowski Z, Pajdo R, Drozdowicz D, Ptak A, Hahn EG.
    Microsc Res Tech; 2001 Jun 01; 53(5):343-53. PubMed ID: 11376495
    [Abstract] [Full Text] [Related]

  • 7. Protective influence of melatonin against acute esophageal lesions involves prostaglandins, nitric oxide and sensory nerves.
    Konturek SJ, Zayachkivska O, Havryluk XO, Brzozowski T, Sliwowski Z, Pawlik M, Konturek PC, Cześnikiewicz-Guzik M, Gzhegotsky MR, Pawlik WW.
    J Physiol Pharmacol; 2007 Jun 01; 58(2):361-77. PubMed ID: 17622703
    [Abstract] [Full Text] [Related]

  • 8. Involvement of cyclooxygenase-derived prostaglandin E2 and nitric oxide in the protection of rat pancreas afforded by low dose of lipopolysaccharide.
    Jaworek J, Bonior J, Tomaszewska R, Jachimczak B, Kot M, Bielański W, Pawlik WW, Sendur R, Stachura J, Konturek PC, Konturek SJ.
    J Physiol Pharmacol; 2001 Mar 01; 52(1):107-26. PubMed ID: 11321505
    [Abstract] [Full Text] [Related]

  • 9. Cyclooxygenase-2 selective and nitric oxide-releasing nonsteroidal anti-inflammatory drugs and gastric mucosal responses.
    Takeuchi K, Suzuki K, Yamamoto H, Araki H, Mizoguchi H, Ukawa H.
    J Physiol Pharmacol; 1998 Dec 01; 49(4):501-13. PubMed ID: 10069692
    [Abstract] [Full Text] [Related]

  • 10. Implications of reactive oxygen species and cytokines in gastroprotection against stress-induced gastric damage by nitric oxide releasing aspirin.
    Brzozowski T, Konturek P, Konturek SJ, Kwiecień S, Sliwowski Z, Pajdo R, Duda A, Ptak A, Hahn EG.
    Int J Colorectal Dis; 2003 Jul 01; 18(4):320-9. PubMed ID: 12774247
    [Abstract] [Full Text] [Related]

  • 11. Nitric oxide-releasing aspirin but not conventional aspirin improves healing of experimental colitis.
    Zwolinska-Wcislo M, Brzozowski T, Ptak-Belowska A, Targosz A, Urbanczyk K, Kwiecien S, Sliwowski Z.
    World J Gastroenterol; 2011 Sep 28; 17(36):4076-89. PubMed ID: 22039321
    [Abstract] [Full Text] [Related]

  • 12. Aspirin, but not NO-releasing aspirin (NCX-4016), interacts with selective COX-2 inhibitors to aggravate gastric damage and inflammation.
    Wallace JL, Zamuner SR, McKnight W, Dicay M, Mencarelli A, del Soldato P, Fiorucci S.
    Am J Physiol Gastrointest Liver Physiol; 2004 Jan 28; 286(1):G76-81. PubMed ID: 14665439
    [Abstract] [Full Text] [Related]

  • 13. Nitric oxide-releasing aspirin protects gastric mucosa against ethanol damage in rats with functional ablation of sensory nerves.
    Konturek PC, Brzozowski T, Kania J, Konturek SJ, Hahn EG.
    Inflamm Res; 2003 Sep 28; 52(9):359-65. PubMed ID: 14504662
    [Abstract] [Full Text] [Related]

  • 14. Biphasic effect of prostaglandin E2 in a rat model of esophagitis mediated by EP1 receptors: relation to pepsin secretion.
    Yamato M, Nagahama K, Kotani T, Kato S, Takeuchi K.
    Digestion; 2005 Sep 28; 72(2-3):109-18. PubMed ID: 16172547
    [Abstract] [Full Text] [Related]

  • 15. NO-releasing aspirin exerts stronger growth inhibitory effect on Barrett's adenocarcinoma cells than traditional aspirin.
    Konturek PC, Kania J, Burnat G, Hahn EG.
    J Physiol Pharmacol; 2006 Dec 28; 57 Suppl 12():15-24. PubMed ID: 17244951
    [Abstract] [Full Text] [Related]

  • 16. Comparison of nitric oxide-releasing NSAID and vitamin C with classic NSAID in healing of chronic gastric ulcers; involvement of reactive oxygen species.
    Brzozowski T, Kwiecień S, Konturek PC, Konturek SJ, Mitis-Musiol M, Duda A, Bielański W, Hahn EG.
    Med Sci Monit; 2001 Dec 28; 7(4):592-9. PubMed ID: 11433182
    [Abstract] [Full Text] [Related]

  • 17. Cyclooxygenase-2 (COX-2) is the key event in pathophysiology of Barrett's esophagus. Lesson from experimental animal model and human subjects.
    Majka J, Rembiasz K, Migaczewski M, Budzynski A, Ptak-Belowska A, Pabianczyk R, Urbanczyk K, Zub-Pokrowiecka A, Matlok M, Brzozowski T.
    J Physiol Pharmacol; 2010 Aug 28; 61(4):409-18. PubMed ID: 20814068
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of endogenous nitric oxide activity impairs the colonic sparing effect of rofecoxib, the cyclooxygenase-2 inhibitor and resveratrol, the preferential cyclooxygenase-1 inhibitor in the course of experimental colitis. Role of oxidative stress biomarkers and proinflammatory cytokines.
    Kwiecień S, Wojcik-Grzybek D, Sliwowski Z, Targosz A, Chmura A, Magierowska K, Strzalka M, Glowacka U, Ptak-Belowska A, Magierowski M, Brzozowski T.
    J Physiol Pharmacol; 2023 Oct 28; 74(5):. PubMed ID: 38085520
    [Abstract] [Full Text] [Related]

  • 19. Renal functional responses to ischaemia-reperfusion injury in normotensive and hypertensive rats following non-selective and selective cyclo-oxygenase inhibition with nitric oxide donation.
    Knight S, Johns EJ.
    Clin Exp Pharmacol Physiol; 2008 Jan 28; 35(1):11-6. PubMed ID: 18047621
    [Abstract] [Full Text] [Related]

  • 20. Gastric acid is the key modulator in the pathogenesis of non-steroidal anti-inflammatory drug-induced ulceration in rats.
    Zinkievich JM, George S, Jha S, Nandi J, Levine RA.
    Clin Exp Pharmacol Physiol; 2010 Jul 28; 37(7):654-61. PubMed ID: 20082628
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 62.